AU2001268951A1 - Modulators of protein tyrosine phosphatases (ptpases) - Google Patents

Modulators of protein tyrosine phosphatases (ptpases)

Info

Publication number
AU2001268951A1
AU2001268951A1 AU2001268951A AU6895101A AU2001268951A1 AU 2001268951 A1 AU2001268951 A1 AU 2001268951A1 AU 2001268951 A AU2001268951 A AU 2001268951A AU 6895101 A AU6895101 A AU 6895101A AU 2001268951 A1 AU2001268951 A1 AU 2001268951A1
Authority
AU
Australia
Prior art keywords
ptpases
modulators
protein tyrosine
tyrosine phosphatases
phosphatases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268951A
Inventor
Henrik Sune Andersen
Frank Urban Axe
Farid Bakir
Yu Ge
Thomas Kruse Hansen
Daniel Dale Holsworth
Luke Milburn Judge
Jesper Lau
Niels Peter Hundahl Moller
Michael James Newman
Ole Hvilsted Olsen
Barry Zvi Shapira
Roy Teruyuki Uyeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Ontogen Corp
Original Assignee
Novo Nordisk AS
Ontogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Ontogen Corp filed Critical Novo Nordisk AS
Publication of AU2001268951A1 publication Critical patent/AU2001268951A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001268951A 2000-07-07 2001-06-28 Modulators of protein tyrosine phosphatases (ptpases) Abandoned AU2001268951A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001066 2000-07-07
DKPA200001066 2000-07-07
PCT/DK2001/000450 WO2002004458A1 (en) 2000-07-07 2001-06-28 Modulators of protein tyrosine phosphatases (ptpases)

Publications (1)

Publication Number Publication Date
AU2001268951A1 true AU2001268951A1 (en) 2002-01-21

Family

ID=8159609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268951A Abandoned AU2001268951A1 (en) 2000-07-07 2001-06-28 Modulators of protein tyrosine phosphatases (ptpases)

Country Status (2)

Country Link
AU (1) AU2001268951A1 (en)
WO (1) WO2002004458A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
KR20040016882A (en) * 2001-06-11 2004-02-25 제노포트 인코포레이티드 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
US6784205B2 (en) * 2002-03-01 2004-08-31 Sunesis Pharmaceuticals, Inc. Compounds that modulate the activity of PTP-1B and TC-PTP
EP1492780B1 (en) 2002-04-03 2011-11-23 Novartis AG 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
EP1628970A2 (en) 2003-04-30 2006-03-01 The Institutes of Pharmaceutical Discovery, LLC Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
EP1482083B1 (en) * 2003-05-27 2007-10-17 Whirlpool Corporation Washing machine with a device for the security during transport
EP1811986B1 (en) 2004-11-04 2014-03-26 XenoPort, Inc. Gabapentin prodrug sustained release oral dosage forms
US20060122222A1 (en) * 2004-11-18 2006-06-08 The Institutes For Pharmaceutical Discovery, Llc Heterocycle substituted carboxylic acids
WO2010118241A2 (en) * 2009-04-08 2010-10-14 Indiana University Research & Technology Corporation Inhibitors of protein tyrosine phosphatases
WO2019195634A1 (en) * 2018-04-04 2019-10-10 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004500308A (en) * 1998-03-12 2004-01-08 ノボ　ノルディスク　アクティーゼルスカブ Modulator of protein tyrosine phosphatase
WO1999046267A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
AU6985200A (en) * 1999-09-10 2001-04-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
AU7476800A (en) * 1999-09-10 2001-04-10 Novo Nordisk A/S Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48

Also Published As

Publication number Publication date
WO2002004458A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2713799A (en) Modulators of protein tyrosine phosphatases (ptpases)
AU2713699A (en) Modulators of protein tyrosine phosphatases (ptpases)
AU2825899A (en) Modulators of protein tyrosine phosphatases (ptpases)
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
NO20004526D0 (en) Modulators for protein tyrosine phosphatases
AU2001277054A1 (en) Antisense modulation of lysophospholipase i expression
AU9253798A (en) Modules of protein tyrosine phosphatases (ptpases)
HUP0104984A3 (en) Modulators of protein tyrosine phosphatases (ptpases) pharmaceutical compositions containing them and their use
AU2002336768A1 (en) Identification of modulatory molecules using inducible promoters
AU2001268951A1 (en) Modulators of protein tyrosine phosphatases (ptpases)
AU2002343356A1 (en) Antisense modulation of protein kinase r expression
AU2002355551A1 (en) Antisense modulation of cholesteryl ester transfer protein expression
AU2002217929A1 (en) Modulation of gene expression using insulator binding proteins
AUPR522501A0 (en) Increased solubilisation of hydrophobic proteins
AU2445601A (en) Mammalian protein phosphatases
AU2001238458A1 (en) Improved assay for protein tyrosine phosphatases
AU2001269888A1 (en) Protein phosphatases
AU5284200A (en) Substrate trapping protein tyrosine phosphatases
AU2001271426A1 (en) Modulation of apoptosis
AU2001283012A1 (en) Protein phosphatases
AU5032501A (en) Use of cationic protein hydrolysates
AU2001292870A1 (en) Protein phosphatases
AU2002213431A1 (en) Modulation of gene expression using localization domains
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2002318933A1 (en) Antisense modulation of dual specific phosphatase 9 expression